Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A N Phillips

Showing results (151-160 of 234) with videos related to

Pageof 24
Sort By:
AIDS (London, England)|July 1, 1996
HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working GroupA N Phillips, J J Eron, J A Bartlett, et al.
Nature|January 13, 1994
Viral burden in HIV infectionA N Phillips, C A Sabin, J Elford, et al.
Genitourinary Medicine|February 1, 1996
Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and menM K Maini, R J Gilson, N Chavda, et al.
AIDS (London, England)|April 15, 1999
Natural immunity and HIV disease progressionH Ullum, A Cozzi Lepri, H Aladdin, et al.
AIDS (London, England)|September 8, 2001
Reduced bone mineral density in HIV-positive individualsA L Moore, A Vashisht, C A Sabin, et al.
AIDS (London, England)|June 19, 1998
Immune status in HIV-1-infected men and boys with haemophilia in the United Kingdom. UK Haemophilia Centre Directors' OrganisationD W Ewart, S C Darby, C A Lee, et al.
HIV Medicine|December 12, 2001
Changing treatment patterns among patients with HIV: Royal Free Hospital 1987-97A Mocroft, C A Sabin, M Youle, et al.
HIV Medicine|November 21, 2008
Factors associated with viral rebound among highly treatment-experienced HIV-positive patients who have achieved viral suppressionC J Smith, A N Phillips, B Dauer, et al.
AIDS (London, England)|December 12, 2001
Durability of HIV-1 viral suppression over 3.3 years with multi-drug antiretroviral therapy in previously drug-naive individualsA N Phillips, V Miller, C Sabin, et al.
AIDS (London, England)|February 1, 1997
Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working GroupA N Phillips, J Eron, J Bartlett, et al.
Pageof 24

Showing results (151-160 of 234) with videos related to

Sort By:
Pageof 24
AIDS (London, England)|July 1, 1996
HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working GroupA N Phillips, J J Eron, J A Bartlett, et al.
Nature|January 13, 1994
Viral burden in HIV infectionA N Phillips, C A Sabin, J Elford, et al.
Genitourinary Medicine|February 1, 1996
Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and menM K Maini, R J Gilson, N Chavda, et al.
AIDS (London, England)|April 15, 1999
Natural immunity and HIV disease progressionH Ullum, A Cozzi Lepri, H Aladdin, et al.
AIDS (London, England)|September 8, 2001
Reduced bone mineral density in HIV-positive individualsA L Moore, A Vashisht, C A Sabin, et al.
AIDS (London, England)|June 19, 1998
Immune status in HIV-1-infected men and boys with haemophilia in the United Kingdom. UK Haemophilia Centre Directors' OrganisationD W Ewart, S C Darby, C A Lee, et al.
HIV Medicine|December 12, 2001
Changing treatment patterns among patients with HIV: Royal Free Hospital 1987-97A Mocroft, C A Sabin, M Youle, et al.
HIV Medicine|November 21, 2008
Factors associated with viral rebound among highly treatment-experienced HIV-positive patients who have achieved viral suppressionC J Smith, A N Phillips, B Dauer, et al.
AIDS (London, England)|December 12, 2001
Durability of HIV-1 viral suppression over 3.3 years with multi-drug antiretroviral therapy in previously drug-naive individualsA N Phillips, V Miller, C Sabin, et al.
AIDS (London, England)|February 1, 1997
Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working GroupA N Phillips, J Eron, J Bartlett, et al.
Pageof 24